BRUGNOLO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 12.353
AS - Asia 1.410
NA - Nord America 836
SA - Sud America 120
AF - Africa 35
OC - Oceania 1
Totale 14.755
Nazione #
IT - Italia 12.137
US - Stati Uniti d'America 787
SG - Singapore 575
CN - Cina 351
VN - Vietnam 262
FR - Francia 93
BD - Bangladesh 75
BR - Brasile 69
HK - Hong Kong 40
CA - Canada 27
DE - Germania 25
FI - Finlandia 23
GB - Regno Unito 22
AR - Argentina 20
JP - Giappone 20
IQ - Iraq 15
CH - Svizzera 12
ID - Indonesia 12
IN - India 12
EC - Ecuador 10
MX - Messico 10
PK - Pakistan 8
IE - Irlanda 7
ZA - Sudafrica 7
CO - Colombia 6
EG - Egitto 6
PH - Filippine 6
RU - Federazione Russa 6
UA - Ucraina 6
DZ - Algeria 5
MA - Marocco 5
TR - Turchia 5
CL - Cile 4
CR - Costa Rica 4
KE - Kenya 4
NL - Olanda 4
TH - Thailandia 4
TW - Taiwan 4
ES - Italia 3
JM - Giamaica 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BE - Belgio 2
BO - Bolivia 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
OM - Oman 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SV - El Salvador 2
UY - Uruguay 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 14.755
Città #
Genova 6.358
Genoa 3.449
Rapallo 1.189
Vado Ligure 913
Singapore 284
San Jose 256
Ashburn 117
Ho Chi Minh City 95
Lauterbourg 78
Beijing 58
Hanoi 58
Hong Kong 39
New York 37
Bordighera 34
Santa Clara 28
Rome 24
Frankfurt am Main 23
Helsinki 23
Tokyo 17
Los Angeles 16
Milan 13
Orem 13
Zurich 11
Council Bluffs 10
Montreal 10
Tianjin 9
São Paulo 8
Da Nang 7
Mexico City 7
Bologna 6
Dublin 6
Hải Dương 6
Palermo 6
Atlanta 5
Chicago 5
Haiphong 5
Jakarta 5
London 5
Naples 5
Paris 5
Phủ Lý 5
Toronto 5
Baghdad 4
Buffalo 4
Cairo 4
Cardiff 4
Dallas 4
Guayaquil 4
Houston 4
Johannesburg 4
Taranto 4
Thái Nguyên 4
Turin 4
Amsterdam 3
Belo Horizonte 3
Brooklyn 3
Changsha 3
City of London 3
Karachi 3
Lahore 3
Miami 3
Pavia 3
Phoenix 3
Piscataway 3
Poplar 3
Shanghai 3
Tashkent 3
Washington 3
Acalanes Ridge 2
Algiers 2
Aurora 2
Bangkok 2
Baton Rouge 2
Bentonville 2
Biên Hòa 2
Boardman 2
Bogotá 2
Brescia 2
Bắc Ninh 2
Bến Tre 2
Cantalupo Ligure 2
Charlotte 2
Cochabamba 2
Correggio 2
Cotia 2
Cullman 2
Córdoba 2
Denver 2
Florence 2
Franca 2
Francavilla Fontana 2
Greenville 2
Huntsville 2
Kansas City 2
Kingston 2
Louisville 2
Marseille 2
Medellín 2
Mendoza 2
Mosul 2
Totale 13.406
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 273
A normative study of the Italian printed word version of the free and cued selective reminding test 228
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 214
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 212
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 201
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 200
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 200
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 194
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 191
Parkinson’s Disease Sleep Scale 2: application in an Italian population 187
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 183
Cortical sources of awake scalp EEG in eating disorders 178
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 178
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 177
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 175
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 174
Early identification of MCI converting to AD: a FDG PET study 173
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 172
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 169
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 169
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 163
What predicts cognitive decline in de novo Parkinson's disease? 163
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 163
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 162
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 162
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 162
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 161
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 157
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 154
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 153
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 151
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 151
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 150
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 149
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 148
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 148
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 148
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 148
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 147
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 146
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 144
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 144
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 144
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 144
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 143
The Von Restorff effect in ageing and Alzheimer's disease. 142
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 142
How can we define a brain health chart? A narrative review and a proposal 141
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 141
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 141
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 140
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 138
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 137
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 135
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 134
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 132
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 130
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 130
Do we need a 99mTc-ECD template for SPM SPECT studies? 128
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 127
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 126
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 125
Principal component analysis of FDG PET in amnestic MCI 122
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 122
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 122
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 122
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 122
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 121
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 121
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 118
MMSE factorial analysis in Alzheimer’s disease. 118
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 117
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 117
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 116
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 115
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 114
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 113
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 112
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 112
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 112
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 110
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 108
Principal component analysis of FDG PET in amnestic MCI 107
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 107
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 106
Cortical sources of awakening scalp EEG in eating disorders. 104
The need of appropriate brain spect templates for spm comparisons 103
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 103
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 103
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 102
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 102
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 101
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 98
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 97
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 97
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 97
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 96
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 93
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 93
Is Euro a cognitive chellenge for the elderly? 92
Totale 14.077
Categoria #
all - tutte 47.823
article - articoli 38.214
book - libri 0
conference - conferenze 8.889
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 720
Totale 95.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/20221.226 32 66 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/20252.335 82 164 52 160 277 280 230 358 111 114 247 260
2025/20263.962 557 141 211 304 501 297 612 219 370 383 262 105
Totale 14.908